enVVeno (NVNO) Market Value to Book Value Ratio

enVVeno - graphic logo of issuer NVNO

enVVeno Medical (NVNO) focuses on the production of innovative vein therapy products, demonstrating high resilience to economic fluctuations and low seasonality. This price trend, valued at 0.23, complements data regarding the creation of a unique valve bioprosthesis. This development ensures the company's leadership in treating venous insufficiency, while the completion of VenoValve testing strengthens its market moat due to a lack of comparable alternatives.

enVVeno Corp (NVNO) Market Capitalization to Net Assets: for the period 07/04/2022 - 10/30/2026

Analytical breakdowns and data insights for company enVVeno Medical Corporation (NVNO)

- market value and analyst target forecast:
Price Chart enVVeno Medical|NVNO - Average Forecast Price
- market capitalization details:
Market Value enVVeno|NVNO - Company Buyout Price
- book capitalization data:
Net Assets per Single Share enVVeno Medical|NVNO - Net Asset Value|Market Capitalization to Book Value Ratio envveno.com|NVNO - Company Assets
- debt level and financial liquidity data:
Total Debt to Capital enVVeno Medical|NVNO - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital enVVeno|NVNO - Company Total Debt Obligations|Debts to Book Capitalization enVVeno|NVNO - Company Long-Term Debts|Company Short-Term Debt enVVeno Medical|Quick Ratio envveno.com
- earnings and market multiples details:
NVNO - Net Financial Result
Analysis of all company metrics:enVVeno Medical - NVNO
Flagship merchandise of enVVeno Medical Corporation

This ratio compares the current market value of the company with its actual net assets, measuring the premium or discount of the market valuation relative to the book value of equity. By analyzing the price-to-book ratio dynamics on the GURU.Markets platform, one can capture the market reaction to corporate events. For enVVeno Medical (NVNO), this gap reflects expectations regarding the FDA. A high multiple here confirms the monopoly potential of bioprostheses, which exceeds the current balance sheet.

Competitor analysis

Boston Scientific (BSX) - Market Value to Book Value Ratio|Market-to-Book Ratio edwards.com (EW)|Market Value to Book Value Ratio ResMed|Insulet Corp (PODD) - Market Capitalization to Book Value|Market Value to Book Value Ratio Zimmer Biomet Holdings, Inc. (ZBH)|COO: Market Capitalization to Net Assets|Market Capitalization to Book Value Ratio ALGN (Align Technology, Inc.)|globusmedical.com (GMED) - Market-to-Book Ratio|TransMedics Group - Market Capitalization to Book Value Ratio|Alphatec Holdings (ATEC) - Market Cap to Net Assets Ratio|AORT: Market Capitalization to Book Value Ratio|ENOV - Market Capitalization to Book Value|IART (Integra LifeSciences) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio establishmentlabs.com|Market Value to Book Value Ratio Beta Bionics (BBNX)|Market Value to Book Value Ratio IRMD (IRADIMED Corp)|Market Capitalization to Book Value Ratio EMBC (Embecta Inc.)|Market Capitalization to Book Value Tandem Corp (TNDM)|AXGN: Market Cap to Net Assets Ratio|Market Capitalization to Net Assets SIBN|OFIX: Market Capitalization to Book Value Ratio|Market-to-Book Ratio Bioventus Inc (BVS)|KIDS (OrthoPediatrics Corp) - Market Capitalization to Book Value Ratio|Capitalization to Book Value Ratio TMCI (Treace Corp)|Market Cap to Net Assets Ratio SRTA (Strata Critical Medical Inc)|CARL (carlsmed.com) - Market Value to Book Value|Market Value to Book Value Ratio RxSight RXST|CLPT - Market Cap to Net Assets Ratio|Stereotaxis Corp - Market Capitalization to Book Value Ratio|Market-to-Book Ratio Neuronetics, Inc|SGHT: Market Capitalization to Book Value Ratio|Capitalization to Book Value Ratio OBIO|ANIK (Anika Therapeutics Inc.) - Market Capitalization to Book Value Ratio|InspireMD Inc (NSPR) - Market Capitalization to Book Value|Market Capitalization to Book Value Ratio ZJYL|Market Cap to Net Assets Ratio vivani.com VANI|Market Capitalization to Book Value Ratio XTNT (Xtant Medical)|Market Capitalization to Book Value Ratio n1mtc.com NMTC|MODD - Market Value to Book Value Ratio|MYO: Market Value to Book Value Ratio|COCH (Envoy Medical, Inc) - Market Cap to Net Assets Ratio|Vivos Therapeutics Inc - Market Value to Book Value|SINT (Sintx Technologies Inc) - Market Capitalization to Book Value Ratio|Market-to-Book Ratio tenonmed.com TNON|Market Value to Book Value Ratio Lifeward (LFWD)|autonomix.com (AMIX) - Market Value to Equity Ratio|INVO Bioscience, Inc. - Market Cap to Net Assets Ratio|Market Capitalization to Book Value Ratio Bone Biologics Inc BBLG|Axonics, Inc. - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value biolase.com BIOL|dynatronics.com (DYNT) - Market Value to Book Value Ratio|Market Capitalization to Net Assets FNA (Paragon 28)|Market Value to Book Value Ratio INVO Bioscience Inc.